ENTITY
Lonza Group AG

Lonza Group AG (LONN VX)

36
Analysis
Health CareSwitzerland
Lonza Group AG produces organic fine chemicals, biocides, active ingredients, and biotechnology products. The Company offers custom chemical manufacturing and fermentation processing and manufactures its products for the life sciences, pharmaceuticals, food processing, and agricultural products industries. Lonza operates production sites in Europe, the United States, and China.
more
bullishWuxi Biologics
17 May 2017 05:40

WuXi Biologics: Updated Valuation Data

We have heard that WuXi Biologics' bankers are preparing to move forward with the offering though a PHIP has not been posted yet.  The updated...

Share
bullishWuxi Biologics
15 Feb 2017 01:41

An Early Look at WuXi Biologics

WuXi Biologics, a CRO/contract manufacturer focused on biologics, has filed an Application Proof with the HKEX for a new listing.  The document...

Share
05 Feb 2017 16:08

Revisiting Samsung BioLogics at This Interesting Time

I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...

Logo
248 Views
Share
15 Nov 2016 03:49

Samsung Biologics IPO: Another Way for the Company's Relative Valuation

We used price/sales ratio for relative valuation of Samsung Biologics Co., Ltd (207940 KS) , a growing company that has yet to show an operating...

11 Nov 2016 06:05

Recap of Samsung BioLogics' First Trading Day - Foreign Institutions Net Purchased 1M Shares

Samsung BioLogics closed at ₩144,000 with 6.67% gain on its first trading day. It started with a relatively weak sentiment at the opening price of...

Logo
205 Views
Share
x